Pancreatic cancer risk in hereditary pancreatitis
Open Access
- 1 January 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 5, 70
Abstract
Inflammation is part of the body’s immune response in order to remove harmful stimuli – like pathogens, irritants or damaged cells - and start the healing process. Recurrent or chronic inflammation on the other side seems a predisposing factor for carcinogenesis and has been found associated with cancer development. In chronic pancreatitis mutations of the cationic trypsinogen (PRSS1) gene have been identified as risk factors of the disease. Hereditary pancreatitis is a rare cause of chronic pancreatic inflammation with an early onset, mostly during childhood. Hereditary pancreatitis often starts with recurrent episodes of acute pancreatitis and the clinical phenotype is not very much different from other etiologies of the disease. The long-lasting inflammation however generates a tumor promoting environment and represents a major risk factor for tumor development This review will reflect our knowledge concerning the specific risk of hereditary pancreatitis patients to develop pancreatic cancer.Keywords
This publication has 37 references indexed in Scilit:
- Clinical and Morphological Characteristics of Sporadic Genetically Determined Pancreatitis as Compared to Idiopathic Pancreatitis: Higher Risk of Pancreatic Cancer in CFTR VariantsDigestion, 2013
- Novel therapeutic strategies targeting tumor-stromal interactions in pancreatic cancerFrontiers in Physiology, 2013
- Increased Activation of Hereditary Pancreatitis-associated Human Cationic Trypsinogen Mutants in Presence of Chymotrypsin CJournal of Biological Chemistry, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinomaCancer, 2009
- Cancer-related inflammationNature, 2008
- Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1Gut, 2007
- Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht's enzyme YProceedings of the National Academy of Sciences, 2007
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisCell, 2006